GlassScriptPhysician profile
Riley Erin Bingham
NPI 1306494315
$2,047.68
in general payments reported to CMS, 2019-2025
19 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $129 · 2023: $990 · 2024: $556 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699 · Travel and Lodging: $8.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.06 |
| Travel and Lodging | $8.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $726.53 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Forte Bio-Pharma LLC | $466.21 | 2023-2024 | Prolate, Nalocet |
| Almatica Pharma LLC | $101.17 | 2021 | |
| Boston Scientific Corporation | $87.74 | 2021-2023 | |
| Biotronik Nro, INC. | $82.70 | 2024-2025 | Prospera |
| Abbvie INC. | $79.36 | 2022-2023 | |
| Ibsa Pharma INC. | $68.60 | 2021-2023 | Tirosint, Licart |
| Azurity Pharmaceuticals, INC. | $68.24 | 2023-2025 | Horizant, Horizant |
| Painteq LLC | $61.21 | 2024 | Painteq |
| Vertex Pharmaceuticals Incorporated | $49.09 | 2024-2025 | |
| Nalu Medical, INC. | $44.39 | 2023 | Nalu Neurostimulation System |
| Arbor Pharmaceuticals, INC. | $42.89 | 2021 | |
| Si-Bone, INC. | $41.65 | 2023 | |
| Saluda Medical Americas, INC. | $32.75 | 2025 | Evoke |
| Averitas Pharma INC. | $29.82 | 2024 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $18.97 | 2022 | |
| Spr Therapeutics, INC | $18.84 | 2025 | Sprint Pns System |
| Curonix LLC | $13.77 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riley Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.